Staar Surgical Co (STAA) Financial Statements
Industry: Ophthalmic Goods
In fiscal 2025, Staar Surgical reported revenue of $239.4M, down 23.7% from $313.9M the year before. Net income was -$80.4M (a -33.6% net margin), or -$1.62 per diluted share. Gross margin was 76.2% and operating margin was -38.3%. Operating activities generated -$34.2M of cash, leaving -$40.0M of free cash flow. At fiscal year end, Staar Surgical held $451.7M in total assets against $107.5M in total liabilities, including $153.2M of cash and equivalents.
Open the full interactive Staar Surgical financials → Quarterly statements, key ratios, valuation history and price charts.
Staar Surgical Key Stats
| Share Price | $21.50 |
|---|---|
| Market Cap | $1.11B |
| Revenue YoY Growth | -23.7% |
| 52-Week Range | $16.10 – $33.34 |
| Shares Outstanding | 50.3 million (basic, 2027 Q2) |
Staar Surgical Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $163.5M | $230.5M | $284.4M | $322.4M | $313.9M | $239.4M |
| Cost of Goods Sold | $45.1M | $51.8M | $61.0M | $69.8M | $74.3M | $57.0M |
| Gross Profit | $118.4M | $178.6M | $223.4M | $252.7M | $239.6M | $182.4M |
| Operating Income | $6.8M | $33.3M | $43.8M | $28.1M | -$12.6M | -$91.7M |
| Pre-Tax Income | $8.3M | $31.3M | $45.6M | $33.7M | -$9.1M | -$82.3M |
| Income Tax | $2.4M | $6.8M | $6.8M | $12.3M | $11.2M | -$1.8M |
| Net Income | $5.9M | $24.5M | $38.8M | $21.3M | -$20.2M | -$80.4M |
| Diluted EPS | $0.12 | $0.50 | $0.78 | $0.43 | -$0.41 | -$1.62 |
Staar Surgical Quarterly Results
| 2025 Q4 | 2026 Q1 | 2026 Q2 | 2027 Q2 | |
|---|---|---|---|---|
| Revenue | $3.1M | $93.5M | $44.3M | $93.5M |
| Net Income | -$42.5M | $5.2M | -$16.8M | $8.1M |
| Diluted EPS | -$0.86 | $0.10 | -$0.34 | $0.16 |
Staar Surgical Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $152.5M | $199.7M | $86.5M | $183.0M | $144.2M | $153.2M |
| Current Assets | $216.4M | $271.4M | $311.7M | $365.3M | $367.9M | $311.5M |
| Total Assets | $257.4M | $345.8M | $414.9M | $488.7M | $509.5M | $451.7M |
| Current Liabilities | $41.2M | $48.8M | $51.7M | $65.0M | $70.3M | $68.5M |
| Total Liabilities | $60.2M | $87.2M | $82.7M | $102.7M | $112.2M | $107.5M |
| Shareholders' Equity | $197.2M | $258.6M | $332.2M | $386.0M | $397.3M | $344.2M |
Staar Surgical Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $21.0M | $44.0M | $35.7M | $14.6M | $15.7M | -$34.2M |
| Cash From Investing | -$8.4M | -$13.6M | -$156.4M | $74.3M | -$59.2M | $46.3M |
| Cash From Financing | $19.6M | $17.8M | $8.3M | $7.4M | $5.7M | -$4.6M |
| Free Cash Flow | $12.5M | $30.3M | $17.6M | -$3.6M | -$7.7M | -$40.0M |
Figures from Staar Surgical's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Staar Surgical financials page for every line item.
Staar Surgical Company Profile
| Ticker | STAA |
|---|---|
| Exchange | Nasdaq |
| Industry | Ophthalmic Goods |
| Headquarters | Monrovia, California |
| Incorporated in | Delaware |
| Fiscal Year End | January 2 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000718937 |
Frequently Asked Questions
What was Staar Surgical's revenue in fiscal 2025?
Staar Surgical (STAA) reported revenue of $239.4M for fiscal 2025.
What is Staar Surgical's annual revenue history?
Staar Surgical's annual revenue by fiscal year: 2020: $163.5M; 2021: $230.5M; 2022: $284.4M; 2023: $322.4M; 2024: $313.9M; 2025: $239.4M.
What was Staar Surgical's net income in fiscal 2025?
Staar Surgical reported net income of -$80.4M for fiscal 2025.
What was Staar Surgical's earnings per share (EPS) in fiscal 2025?
Staar Surgical's diluted EPS was -$1.62 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Staar Surgical generate in fiscal 2025?
Staar Surgical generated -$40.0M of free cash flow in fiscal 2025.
What was Staar Surgical's revenue last quarter?
In its most recent reported quarter (2027 Q2), Staar Surgical reported revenue of $93.5M.
How many shares of Staar Surgical are outstanding?
Staar Surgical reported a weighted average of 50.3 million basic shares outstanding in 2027 Q2.
What is Staar Surgical's market cap?
Based on its latest closing price, Staar Surgical (STAA) has a market capitalization of about $1.11B.
When does Staar Surgical's fiscal year end?
Staar Surgical's fiscal year end, as registered with the SEC, is January 2.
Where is Staar Surgical headquartered?
Staar Surgical lists its business address in Monrovia, California in its SEC filings.